249
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Effects of high-intensity high-frequency transcutaneous electric nerve stimulation in primary dysmenorrhea – a randomised cross-over pilot study

, , , , &
Pages 248-252 | Received 03 Jan 2019, Accepted 19 Feb 2019, Published online: 26 Mar 2019
 

Abstract

Background: Many women are affected by primary dysmenorrhoea. Transcutaneous Electric Nerve Stimulation (TENS) can be an alternative to analgesics. In one trial, high-intensity, high-frequency TENS was shown to be effective but there is need for more trials.

Objectives: To study the effects of high-intensity, high-frequency TENS for primary dysmenorrhoea.

Design: Randomised controlled pilot study with cross over design.

Methods: Sixteen women with primary dysmenorrhoea participated. Pain, limitation in physical function, other symptoms related to the menstrual period and use of analgesics were registered at baseline, treatment versus control period followed by a wash-out period. Treatment consisted of high-intensity (40 mA) high-frequency (80 Hz) TENS stimulation in sessions of 60 s.

Results: The results revealed no significant difference in pain intensity, limitations in physical function, consumption of analgesics and associated symptoms between the groups but a significant lower limitation in physical function during the wash-out period in comparison to the treatment period within the whole group.

Conclusion: No significant effect of TENS was seen in contrast to previous studies. The effect is therefore questionable, but results must be interpreted with care, as this was a pilot study and the use of the equipment was not monitored and therefore unknown.

Trial registration: FoU i Sverige, R&D in Sweden. Registration number: 257041, 181009, First patient enrolled: June 15, 2016

Acknowledgement

The authors thank DJA Nordic AB, Malmö, Sweden for supporting the trial with electrodes and gel.

Ethical approval

The regional Ethics Committee for the region of Västra Götaland, Sweden approved the study protocol (Registration number 705-16).

Disclosure statement

The authors report no conflicts of interest. The trial was undertaken without financial support.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.